George Soros Boosts Nvidia and TSMC Stakes and Opens Coinbase Position in Latest TradesFebruary 20, 2026
Cardano (ADA) Price Analysis: $200M Midnight Investment as Whales Accumulate 220M TokensApril 1, 2026
Stock Samsung and SK Hynix Stocks Surge Over 10% Amid Iran Ceasefire OptimismBy Trader EdgeApril 1, 2026
News Crude Oil Dips Under $100 Mark Following Trump’s Iran Withdrawal RemarksBy Trader EdgeApril 1, 2026
Stock Nike (NKE) Stock Plunges 10% on Disappointing Forecast and China Revenue WoesBy Trader EdgeApril 1, 2026
Stock SpaceX Assembles 21-Bank Coalition for Massive $1.75 Trillion Public DebutBy Trader EdgeApril 1, 2026
Stock Marvell (MRVL) Stock Soars 13% on Nvidia Deal as BofA Upgrades Price Target to $125By Trader EdgeApril 1, 2026
Stock ARK Invest Secures $240M OpenAI Stake Across Three ETFs Ahead of Public OfferingBy Trader EdgeApril 1, 2026
Stock Microsoft (MSFT) Commits $5.5B to Singapore Cloud and AI Expansion Through 2029By Trader EdgeApril 1, 2026
Stock Amazon (AMZN) Ditches Amex for U.S. Bank in Major Small Business Credit Card OverhaulBy Trader EdgeApril 1, 2026
Stock Rocket Lab (RKLB) Stock Soars 12% on Mynaric Acquisition Approval — Analysts Remain OptimisticBy Trader EdgeApril 1, 2026
Stock Samsung Electronics (0L2T.L) Stock: Climbs as Foldable Prices Rise on Cost PressuresBy Newton KitongaApril 1, 2026
Stock Oracle (ORCL) Stock: Under Pressure as OpenAI Deal Fuels Capex SurgeBy Newton KitongaApril 1, 2026
Crypto Markets Surge as Iran Signals Openness to Peace: Bitcoin and Stocks JumpBy Trader EdgeApril 1, 2026
Crypto Trump Announces 2-3 Week Iran Exit Timeline — Bitcoin and Equities RallyBy Trader EdgeApril 1, 2026
Stock TSMC (TSM) Stock: Rallies on Plans for 3nm Chip Production in Japan’s $17B AI Expansion PushBy Newton KitongaApril 1, 2026
Stock FedEx (FDX) Stock: Gains as Robotics Partnerships Drive Warehouse Automation PushBy Newton KitongaApril 1, 2026
Stock Nvidia (NVDA) Stock: Surges After $2B Marvell Investment Fuels AI Chip Strategy ShiftBy Newton KitongaApril 1, 2026
Stock Pfizer (PFE) Stock: Climbs on Oncology Trial Wins Despite Bearish 45% Downside OutlookBy Newton KitongaApril 1, 2026
